Interventional treatment of patent ductus arteriosus in 2004

Abstract

In 2004, the interventional treatment of patent ductus arteriosus (PDA) is definitive and curative. In current practice, coils are used for smaller PDA, and devices are employed for larger PDA. Developing technologies offer small improvements in control and results, but do not appear to promise major changes in practice. This review summarizes the current and emerging interventional technologies directed at PDA closures.

Aortic valve regurgitation following percutaneous closure of patent ductus arteriosus

“…Currently, patent ductus arteriosus (PDA) is most often closed percutaneously [1]. Coils are usually used for closure of small PDA and Amplatzer Duct Occluders (ADO) for closure of moderate and large PDA [2][3][4].…”

Echocardiograpic Evaluation of Short-term Outcome of Patent Ductus Arteriosus Closure using Amplatzer Occluder Device

“…The physiological impact and clinical significance of PDA depend largely on its size and the underlying cardiovascular status of the patient, so patients with large PDA may develop left-sided volume overload and pulmonary hypertension at younger ages, leading to diagnosis early in life. If left untreated, PDA can foster the development of infective endarteritis, Eisenmenger syndrome, and other conditions, with an annual mortality rate of 1.8% [3][4][5]. Ductus closure is clearly indicated for any child or adult who is symptomatic from significant left-to-right shunting through PDA [3].…”

Successful Closure of a Patent Ductus Arteriosus Using an Aortic Stent Graft

“…Thus, an extremely large or window-type PDA (as in our case) are not appropriately closed with these procedures. Placement of these devices may apply localized forces to the aneurysm, leading to dissection or rupture 6) and migration of the occlusion device.…”